Loading...
Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial
BACKGROUND: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated peripheral neuropathy that is currently classified into several clinical subtypes, which are presumed to have different pathogenic mechanisms. Recently, studies identified a subgroup of patients with C...
Na minha lista:
| Udgivet i: | JMIR Res Protoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JMIR Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160709/ https://ncbi.nlm.nih.gov/pubmed/32234705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/17117 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|